Cooler Heads Secures $11M Series A Funding to Expand FDA-Cleared Scalp Cooling System for Chemotherapy Patients
Cooler Heads, a trailblazing medical device company, has successfully closed an oversubscribed $11 million Series A funding round to accelerate the manufacturing and commercial rollout of Amma™, the first and only FDA-cleared Portable Scalp Cooling System designed to reduce chemotherapy-induced hair loss. Amma™ offers a groundbreaking solution to one of the most distressing side effects … Read more